# LO-ZUMANDIMINE
> **ANDA209632** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2018-02-27
## Drug
- **FDA Application Number:** ANDA209632
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LO-ZUMANDIMINE
- **Generic name:** DROSPIRENONE AND ETHINYL ESTRADIOL
- **Active ingredients:** DROSPIRENONE; ETHINYL ESTRADIOL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA LTD
- **Manufacturer:** NorthStar Rx LLC
- **First approval:** 2018-02-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209632)
---
*AI Analytics · CC0 1.0*